Senior people are crucial contributors to society and the economy.
Untreated heart valve disease (HVD) is a barrier to active aging but conversely, early detection and timely treatment will increase longevity and quality of life.
For heart valve disease, symptoms like shortness of breath, fatigue, dizziness, and chest pain are too often dismissed as “just a normal part of getting old.” This ageist assumption impedes detection, slows the path to diagnosis, and limits a person’s ability to access interventions. These delays can have tragic consequences. When untreated, severe, symptomatic aortic stenosis, the most common type of heart valve disease, has a mortality rate between 25 and 50 percent per year.
Global Heart Hub’s Heart Valve Disease Patient Council has collaborated with Global Coalition on Aging, the world’s leading business voice on aging-related policy and strategy, to develop a position paper on Heart Valve Disease and the Healthy Aging Agenda, aiming to build a firm base for a policy imperative across the world to tackle HVD given that it is a barrier in active and healthy ageing with huge economic consequences.